MBD4 and cutaneous melanoma: The high TMB in iris UM reported here suggests they are more likely to respond to immunotherapy, given the observations for MBD4 germline UM patients14,15, who have high TMB, a predictor of response to immunotherapy response in cutaneous melanoma and other cancers47.